Dr. Tew Evaluates Avastin Treatment in Ovarian Cancer

William P. Tew, MD
Published: Thursday, Mar 24, 2011

William P. Tew, MD, a Gynecologic Medical Oncologist at Memorial Sloan-Kettering Cancer Center in New York, evaluates the angiogenesis inhibitor bevacizumab (Avastin) as a treatment for women with ovarian cancer, at the 2010 ASCO Annual Meeting.
William P. Tew, MD, a Gynecologic Medical Oncologist at Memorial Sloan-Kettering Cancer Center in New York, evaluates the angiogenesis inhibitor bevacizumab (Avastin) as a treatment for women with ovarian cancer, at the 2010 ASCO Annual Meeting.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x